Friday, August 26, 2016 4:45:48 PM
$173,638,778,550
Debt Securities
Preferred Stock
Depositary Shares
Common Stock
Warrants
Units
Up to $173,638,778,550, or the equivalent thereof in any other currency, of these securities may be offered from time to time, in amounts, on terms and at prices that will be determined at the time they are offered for sale. These terms and prices will be described in more detail in one or more supplements to this prospectus, which will be distributed at the time the securities are offered. Our common stock is listed on the New York Stock Exchange under the symbol “JPM.” The other securities that we may offer from time to time under this prospectus may be listed on the New York Stock Exchange or another national securities exchange, as specified in the applicable prospectus supplement.
$125,000,000,000
Debt Securities
Preferred Stock
Depositary Shares
Common Stock
Warrants
Units
Up to $125,000,000,000, or the equivalent thereof in any other currency, these securities may be offered from time to time, in amounts, on terms and at prices that will be determined at the time they are offered for sale. These terms and prices will be described in more detail in one or more supplements to this prospectus, which will be distributed at the time the securities are offered.
$40,000,000,000
Debt Securities
Preferred Stock
Depositary Shares
Common Stock
Warrants
Units
Up to $40,000,000,000, or the equivalent thereof in any other currency, of these securities may be offered from time to time, in amounts, on terms and at prices that will be determined at the time they are offered for sale. These terms and prices will be described in more detail in one or more supplements to this prospectus, which will be distributed at the time the securities are offered.
Explanatory Note
This Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 (File No. 333-191692) is being filed to include information that is required to be included in the Registration Statement by such form for registrants that are no longer well-known seasoned issuers, as defined in Rule 405 under the Securities Act of 1933, as amended. This Post-Effective Amendment No. 1 contains:
• a prospectus to be used by JPMorgan Chase & Co. in connection with offerings of up to $40,000,000,000, or the equivalent thereof in any other currency, of its debt securities, preferred stock, depositary shares representing its preferred stock, common stock, warrants and units at unspecified aggregate initial public offering prices and by affiliates of JPMorgan Chase & Co. in connection with market-making transactions from time to time in the securities described therein after they are initially offered and sold; and
• a prospectus addendum to be used by affiliates of JPMorgan Chase & Co. in connection with market-making transactions from time to time in securities of one or more of the same classes, as well as purchase contracts, that were initially registered under registration statements previously filed by JPMorgan Chase & Co. or its affiliates and that were initially offered and sold prior to the date of the abovementioned prospectus addendum.
Recent COOP News
- Mr. Cooper Group Reports First Quarter 2024 Results • Business Wire • 04/24/2024 11:00:00 AM
- Mr. Cooper Group Announces Two New Senior Leaders • Business Wire • 04/23/2024 01:00:00 PM
- Mr. Cooper Group Inc. to Discuss First Quarter 2024 Financial Results on April 24, 2024 • Business Wire • 04/05/2024 03:37:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:34:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:04:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:03:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:59:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:28:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:15:59 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:13:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 12:00:29 PM
- Mr. Cooper Group Reports Fourth Quarter 2023 Results • Business Wire • 02/09/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:26:40 PM
- Mr. Cooper Group Inc. Announces Pricing of Offering of $1 Billion of Senior Notes • Business Wire • 01/29/2024 11:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 12:55:56 PM
- Mr. Cooper Group Inc. to Discuss Fourth Quarter 2023 Financial Results on February 9, 2024 • Business Wire • 01/11/2024 09:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:00:53 PM
- Mr. Cooper Group Appoints Mike Weinbach as President • Business Wire • 01/09/2024 09:00:00 PM
- Meta CEO Sells $428 Million in Shares Since November, AMC Hits New Record Low, and More • IH Market News • 01/04/2024 09:51:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2023 08:45:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:08:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM